Global Viral Vaccines Market Growth 2024-2030
The report requires updating with new data and is sent in 48 hours after order is placed.
According to our LPI (LP Information) latest study, the global Viral Vaccines market size was valued at US$ million in 2023. With growing demand in downstream market, the Viral Vaccines is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Viral Vaccines market. Viral Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Viral Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Viral Vaccines market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Viral Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Viral Vaccines market. It may include historical data, market segmentation by Type (e.g., Attenuated Vaccine, Inactivated Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Viral Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Viral Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Viral Vaccines industry. This include advancements in Viral Vaccines technology, Viral Vaccines new entrants, Viral Vaccines new investment, and other innovations that are shaping the future of Viral Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Viral Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Viral Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Viral Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Viral Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Viral Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Viral Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Viral Vaccines market.
Market Segmentation:
Viral Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
What is the 10-year outlook for the global Viral Vaccines market?
What factors are driving Viral Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Viral Vaccines market opportunities vary by end market size?
How does Viral Vaccines break out type, application?
According to our LPI (LP Information) latest study, the global Viral Vaccines market size was valued at US$ million in 2023. With growing demand in downstream market, the Viral Vaccines is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.
The research report highlights the growth potential of the global Viral Vaccines market. Viral Vaccines are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Viral Vaccines. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Viral Vaccines market.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The report on Viral Vaccines market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Viral Vaccines market. It may include historical data, market segmentation by Type (e.g., Attenuated Vaccine, Inactivated Vaccine), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Viral Vaccines market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Viral Vaccines market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Viral Vaccines industry. This include advancements in Viral Vaccines technology, Viral Vaccines new entrants, Viral Vaccines new investment, and other innovations that are shaping the future of Viral Vaccines.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Viral Vaccines market. It includes factors influencing customer ' purchasing decisions, preferences for Viral Vaccines product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Viral Vaccines market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Viral Vaccines market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Viral Vaccines market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Viral Vaccines industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Viral Vaccines market.
Market Segmentation:
Viral Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Segmentation by type
- Attenuated Vaccine
- Inactivated Vaccine
- Hospital
- Pharmaceutical Factory
- Research Institute
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- GSK
- Merck
- Novartis
- Pfizer
- Sanofi
- Bayer
- Zoetis
- AstraZeneca
- Johnson
- CSL
What is the 10-year outlook for the global Viral Vaccines market?
What factors are driving Viral Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Viral Vaccines market opportunities vary by end market size?
How does Viral Vaccines break out type, application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Viral Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Viral Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Viral Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Viral Vaccines Segment by Type
2.2.1 Attenuated Vaccine
2.2.2 Inactivated Vaccine
2.3 Viral Vaccines Sales by Type
2.3.1 Global Viral Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Viral Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Viral Vaccines Sale Price by Type (2019-2024)
2.4 Viral Vaccines Segment by Application
2.4.1 Hospital
2.4.2 Pharmaceutical Factory
2.4.3 Research Institute
2.4.4 Others
2.5 Viral Vaccines Sales by Application
2.5.1 Global Viral Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Viral Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Viral Vaccines Sale Price by Application (2019-2024)
3 GLOBAL VIRAL VACCINES BY COMPANY
3.1 Global Viral Vaccines Breakdown Data by Company
3.1.1 Global Viral Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Viral Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Viral Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Viral Vaccines Revenue by Company (2019-2024)
3.2.2 Global Viral Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Viral Vaccines Sale Price by Company
3.4 Key Manufacturers Viral Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Viral Vaccines Product Location Distribution
3.4.2 Players Viral Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VIRAL VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Viral Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Viral Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Viral Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Viral Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Viral Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Viral Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Viral Vaccines Sales Growth
4.4 APAC Viral Vaccines Sales Growth
4.5 Europe Viral Vaccines Sales Growth
4.6 Middle East & Africa Viral Vaccines Sales Growth
5 AMERICAS
5.1 Americas Viral Vaccines Sales by Country
5.1.1 Americas Viral Vaccines Sales by Country (2019-2024)
5.1.2 Americas Viral Vaccines Revenue by Country (2019-2024)
5.2 Americas Viral Vaccines Sales by Type
5.3 Americas Viral Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viral Vaccines Sales by Region
6.1.1 APAC Viral Vaccines Sales by Region (2019-2024)
6.1.2 APAC Viral Vaccines Revenue by Region (2019-2024)
6.2 APAC Viral Vaccines Sales by Type
6.3 APAC Viral Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Viral Vaccines by Country
7.1.1 Europe Viral Vaccines Sales by Country (2019-2024)
7.1.2 Europe Viral Vaccines Revenue by Country (2019-2024)
7.2 Europe Viral Vaccines Sales by Type
7.3 Europe Viral Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Viral Vaccines by Country
8.1.1 Middle East & Africa Viral Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Viral Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Viral Vaccines Sales by Type
8.3 Middle East & Africa Viral Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Viral Vaccines
10.3 Manufacturing Process Analysis of Viral Vaccines
10.4 Industry Chain Structure of Viral Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Viral Vaccines Distributors
11.3 Viral Vaccines Customer
12 WORLD FORECAST REVIEW FOR VIRAL VACCINES BY GEOGRAPHIC REGION
12.1 Global Viral Vaccines Market Size Forecast by Region
12.1.1 Global Viral Vaccines Forecast by Region (2025-2030)
12.1.2 Global Viral Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Viral Vaccines Forecast by Type
12.7 Global Viral Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Viral Vaccines Product Portfolios and Specifications
13.1.3 GSK Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Viral Vaccines Product Portfolios and Specifications
13.2.3 Merck Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Viral Vaccines Product Portfolios and Specifications
13.3.3 Novartis Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Viral Vaccines Product Portfolios and Specifications
13.4.3 Pfizer Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Viral Vaccines Product Portfolios and Specifications
13.5.3 Sanofi Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Bayer
13.6.1 Bayer Company Information
13.6.2 Bayer Viral Vaccines Product Portfolios and Specifications
13.6.3 Bayer Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Bayer Main Business Overview
13.6.5 Bayer Latest Developments
13.7 Zoetis
13.7.1 Zoetis Company Information
13.7.2 Zoetis Viral Vaccines Product Portfolios and Specifications
13.7.3 Zoetis Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Zoetis Main Business Overview
13.7.5 Zoetis Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Viral Vaccines Product Portfolios and Specifications
13.8.3 AstraZeneca Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Johnson
13.9.1 Johnson Company Information
13.9.2 Johnson Viral Vaccines Product Portfolios and Specifications
13.9.3 Johnson Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Johnson Main Business Overview
13.9.5 Johnson Latest Developments
13.10 CSL
13.10.1 CSL Company Information
13.10.2 CSL Viral Vaccines Product Portfolios and Specifications
13.10.3 CSL Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 CSL Main Business Overview
13.10.5 CSL Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Viral Vaccines Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Viral Vaccines by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Viral Vaccines by Country/Region, 2019, 2023 & 2030
2.2 Viral Vaccines Segment by Type
2.2.1 Attenuated Vaccine
2.2.2 Inactivated Vaccine
2.3 Viral Vaccines Sales by Type
2.3.1 Global Viral Vaccines Sales Market Share by Type (2019-2024)
2.3.2 Global Viral Vaccines Revenue and Market Share by Type (2019-2024)
2.3.3 Global Viral Vaccines Sale Price by Type (2019-2024)
2.4 Viral Vaccines Segment by Application
2.4.1 Hospital
2.4.2 Pharmaceutical Factory
2.4.3 Research Institute
2.4.4 Others
2.5 Viral Vaccines Sales by Application
2.5.1 Global Viral Vaccines Sale Market Share by Application (2019-2024)
2.5.2 Global Viral Vaccines Revenue and Market Share by Application (2019-2024)
2.5.3 Global Viral Vaccines Sale Price by Application (2019-2024)
3 GLOBAL VIRAL VACCINES BY COMPANY
3.1 Global Viral Vaccines Breakdown Data by Company
3.1.1 Global Viral Vaccines Annual Sales by Company (2019-2024)
3.1.2 Global Viral Vaccines Sales Market Share by Company (2019-2024)
3.2 Global Viral Vaccines Annual Revenue by Company (2019-2024)
3.2.1 Global Viral Vaccines Revenue by Company (2019-2024)
3.2.2 Global Viral Vaccines Revenue Market Share by Company (2019-2024)
3.3 Global Viral Vaccines Sale Price by Company
3.4 Key Manufacturers Viral Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Viral Vaccines Product Location Distribution
3.4.2 Players Viral Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR VIRAL VACCINES BY GEOGRAPHIC REGION
4.1 World Historic Viral Vaccines Market Size by Geographic Region (2019-2024)
4.1.1 Global Viral Vaccines Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Viral Vaccines Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Viral Vaccines Market Size by Country/Region (2019-2024)
4.2.1 Global Viral Vaccines Annual Sales by Country/Region (2019-2024)
4.2.2 Global Viral Vaccines Annual Revenue by Country/Region (2019-2024)
4.3 Americas Viral Vaccines Sales Growth
4.4 APAC Viral Vaccines Sales Growth
4.5 Europe Viral Vaccines Sales Growth
4.6 Middle East & Africa Viral Vaccines Sales Growth
5 AMERICAS
5.1 Americas Viral Vaccines Sales by Country
5.1.1 Americas Viral Vaccines Sales by Country (2019-2024)
5.1.2 Americas Viral Vaccines Revenue by Country (2019-2024)
5.2 Americas Viral Vaccines Sales by Type
5.3 Americas Viral Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Viral Vaccines Sales by Region
6.1.1 APAC Viral Vaccines Sales by Region (2019-2024)
6.1.2 APAC Viral Vaccines Revenue by Region (2019-2024)
6.2 APAC Viral Vaccines Sales by Type
6.3 APAC Viral Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Viral Vaccines by Country
7.1.1 Europe Viral Vaccines Sales by Country (2019-2024)
7.1.2 Europe Viral Vaccines Revenue by Country (2019-2024)
7.2 Europe Viral Vaccines Sales by Type
7.3 Europe Viral Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Viral Vaccines by Country
8.1.1 Middle East & Africa Viral Vaccines Sales by Country (2019-2024)
8.1.2 Middle East & Africa Viral Vaccines Revenue by Country (2019-2024)
8.2 Middle East & Africa Viral Vaccines Sales by Type
8.3 Middle East & Africa Viral Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Viral Vaccines
10.3 Manufacturing Process Analysis of Viral Vaccines
10.4 Industry Chain Structure of Viral Vaccines
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Viral Vaccines Distributors
11.3 Viral Vaccines Customer
12 WORLD FORECAST REVIEW FOR VIRAL VACCINES BY GEOGRAPHIC REGION
12.1 Global Viral Vaccines Market Size Forecast by Region
12.1.1 Global Viral Vaccines Forecast by Region (2025-2030)
12.1.2 Global Viral Vaccines Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Viral Vaccines Forecast by Type
12.7 Global Viral Vaccines Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 GSK
13.1.1 GSK Company Information
13.1.2 GSK Viral Vaccines Product Portfolios and Specifications
13.1.3 GSK Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 GSK Main Business Overview
13.1.5 GSK Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Viral Vaccines Product Portfolios and Specifications
13.2.3 Merck Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Viral Vaccines Product Portfolios and Specifications
13.3.3 Novartis Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Pfizer
13.4.1 Pfizer Company Information
13.4.2 Pfizer Viral Vaccines Product Portfolios and Specifications
13.4.3 Pfizer Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Pfizer Main Business Overview
13.4.5 Pfizer Latest Developments
13.5 Sanofi
13.5.1 Sanofi Company Information
13.5.2 Sanofi Viral Vaccines Product Portfolios and Specifications
13.5.3 Sanofi Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Sanofi Main Business Overview
13.5.5 Sanofi Latest Developments
13.6 Bayer
13.6.1 Bayer Company Information
13.6.2 Bayer Viral Vaccines Product Portfolios and Specifications
13.6.3 Bayer Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Bayer Main Business Overview
13.6.5 Bayer Latest Developments
13.7 Zoetis
13.7.1 Zoetis Company Information
13.7.2 Zoetis Viral Vaccines Product Portfolios and Specifications
13.7.3 Zoetis Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Zoetis Main Business Overview
13.7.5 Zoetis Latest Developments
13.8 AstraZeneca
13.8.1 AstraZeneca Company Information
13.8.2 AstraZeneca Viral Vaccines Product Portfolios and Specifications
13.8.3 AstraZeneca Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 AstraZeneca Main Business Overview
13.8.5 AstraZeneca Latest Developments
13.9 Johnson
13.9.1 Johnson Company Information
13.9.2 Johnson Viral Vaccines Product Portfolios and Specifications
13.9.3 Johnson Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 Johnson Main Business Overview
13.9.5 Johnson Latest Developments
13.10 CSL
13.10.1 CSL Company Information
13.10.2 CSL Viral Vaccines Product Portfolios and Specifications
13.10.3 CSL Viral Vaccines Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 CSL Main Business Overview
13.10.5 CSL Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Viral Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Viral Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Attenuated Vaccine
Table 4. Major Players of Inactivated Vaccine
Table 5. Global Viral Vaccines Sales by Type (2019-2024) & (K MT)
Table 6. Global Viral Vaccines Sales Market Share by Type (2019-2024)
Table 7. Global Viral Vaccines Revenue by Type (2019-2024) & ($ million)
Table 8. Global Viral Vaccines Revenue Market Share by Type (2019-2024)
Table 9. Global Viral Vaccines Sale Price by Type (2019-2024) & (USD/MT)
Table 10. Global Viral Vaccines Sales by Application (2019-2024) & (K MT)
Table 11. Global Viral Vaccines Sales Market Share by Application (2019-2024)
Table 12. Global Viral Vaccines Revenue by Application (2019-2024)
Table 13. Global Viral Vaccines Revenue Market Share by Application (2019-2024)
Table 14. Global Viral Vaccines Sale Price by Application (2019-2024) & (USD/MT)
Table 15. Global Viral Vaccines Sales by Company (2019-2024) & (K MT)
Table 16. Global Viral Vaccines Sales Market Share by Company (2019-2024)
Table 17. Global Viral Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Viral Vaccines Revenue Market Share by Company (2019-2024)
Table 19. Global Viral Vaccines Sale Price by Company (2019-2024) & (USD/MT)
Table 20. Key Manufacturers Viral Vaccines Producing Area Distribution and Sales Area
Table 21. Players Viral Vaccines Products Offered
Table 22. Viral Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Viral Vaccines Sales by Geographic Region (2019-2024) & (K MT)
Table 26. Global Viral Vaccines Sales Market Share Geographic Region (2019-2024)
Table 27. Global Viral Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Viral Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Viral Vaccines Sales by Country/Region (2019-2024) & (K MT)
Table 30. Global Viral Vaccines Sales Market Share by Country/Region (2019-2024)
Table 31. Global Viral Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Viral Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Viral Vaccines Sales by Country (2019-2024) & (K MT)
Table 34. Americas Viral Vaccines Sales Market Share by Country (2019-2024)
Table 35. Americas Viral Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Viral Vaccines Revenue Market Share by Country (2019-2024)
Table 37. Americas Viral Vaccines Sales by Type (2019-2024) & (K MT)
Table 38. Americas Viral Vaccines Sales by Application (2019-2024) & (K MT)
Table 39. APAC Viral Vaccines Sales by Region (2019-2024) & (K MT)
Table 40. APAC Viral Vaccines Sales Market Share by Region (2019-2024)
Table 41. APAC Viral Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Viral Vaccines Revenue Market Share by Region (2019-2024)
Table 43. APAC Viral Vaccines Sales by Type (2019-2024) & (K MT)
Table 44. APAC Viral Vaccines Sales by Application (2019-2024) & (K MT)
Table 45. Europe Viral Vaccines Sales by Country (2019-2024) & (K MT)
Table 46. Europe Viral Vaccines Sales Market Share by Country (2019-2024)
Table 47. Europe Viral Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Viral Vaccines Revenue Market Share by Country (2019-2024)
Table 49. Europe Viral Vaccines Sales by Type (2019-2024) & (K MT)
Table 50. Europe Viral Vaccines Sales by Application (2019-2024) & (K MT)
Table 51. Middle East & Africa Viral Vaccines Sales by Country (2019-2024) & (K MT)
Table 52. Middle East & Africa Viral Vaccines Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Viral Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Viral Vaccines Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Viral Vaccines Sales by Type (2019-2024) & (K MT)
Table 56. Middle East & Africa Viral Vaccines Sales by Application (2019-2024) & (K MT)
Table 57. Key Market Drivers & Growth Opportunities of Viral Vaccines
Table 58. Key Market Challenges & Risks of Viral Vaccines
Table 59. Key Industry Trends of Viral Vaccines
Table 60. Viral Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Viral Vaccines Distributors List
Table 63. Viral Vaccines Customer List
Table 64. Global Viral Vaccines Sales Forecast by Region (2025-2030) & (K MT)
Table 65. Global Viral Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Viral Vaccines Sales Forecast by Country (2025-2030) & (K MT)
Table 67. Americas Viral Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Viral Vaccines Sales Forecast by Region (2025-2030) & (K MT)
Table 69. APAC Viral Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Viral Vaccines Sales Forecast by Country (2025-2030) & (K MT)
Table 71. Europe Viral Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Viral Vaccines Sales Forecast by Country (2025-2030) & (K MT)
Table 73. Middle East & Africa Viral Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Viral Vaccines Sales Forecast by Type (2025-2030) & (K MT)
Table 75. Global Viral Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Viral Vaccines Sales Forecast by Application (2025-2030) & (K MT)
Table 77. Global Viral Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. GSK Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Viral Vaccines Product Portfolios and Specifications
Table 80. GSK Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Merck Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Viral Vaccines Product Portfolios and Specifications
Table 85. Merck Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Novartis Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Viral Vaccines Product Portfolios and Specifications
Table 90. Novartis Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Pfizer Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Viral Vaccines Product Portfolios and Specifications
Table 95. Pfizer Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Sanofi Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Viral Vaccines Product Portfolios and Specifications
Table 100. Sanofi Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 101. Sanofi Main Business
Table 102. Sanofi Latest Developments
Table 103. Bayer Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Bayer Viral Vaccines Product Portfolios and Specifications
Table 105. Bayer Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 106. Bayer Main Business
Table 107. Bayer Latest Developments
Table 108. Zoetis Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Zoetis Viral Vaccines Product Portfolios and Specifications
Table 110. Zoetis Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 111. Zoetis Main Business
Table 112. Zoetis Latest Developments
Table 113. AstraZeneca Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. AstraZeneca Viral Vaccines Product Portfolios and Specifications
Table 115. AstraZeneca Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 116. AstraZeneca Main Business
Table 117. AstraZeneca Latest Developments
Table 118. Johnson Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Johnson Viral Vaccines Product Portfolios and Specifications
Table 120. Johnson Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 121. Johnson Main Business
Table 122. Johnson Latest Developments
Table 123. CSL Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. CSL Viral Vaccines Product Portfolios and Specifications
Table 125. CSL Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 126. CSL Main Business
Table 127. CSL Latest Developments
Table 1. Viral Vaccines Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Viral Vaccines Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Attenuated Vaccine
Table 4. Major Players of Inactivated Vaccine
Table 5. Global Viral Vaccines Sales by Type (2019-2024) & (K MT)
Table 6. Global Viral Vaccines Sales Market Share by Type (2019-2024)
Table 7. Global Viral Vaccines Revenue by Type (2019-2024) & ($ million)
Table 8. Global Viral Vaccines Revenue Market Share by Type (2019-2024)
Table 9. Global Viral Vaccines Sale Price by Type (2019-2024) & (USD/MT)
Table 10. Global Viral Vaccines Sales by Application (2019-2024) & (K MT)
Table 11. Global Viral Vaccines Sales Market Share by Application (2019-2024)
Table 12. Global Viral Vaccines Revenue by Application (2019-2024)
Table 13. Global Viral Vaccines Revenue Market Share by Application (2019-2024)
Table 14. Global Viral Vaccines Sale Price by Application (2019-2024) & (USD/MT)
Table 15. Global Viral Vaccines Sales by Company (2019-2024) & (K MT)
Table 16. Global Viral Vaccines Sales Market Share by Company (2019-2024)
Table 17. Global Viral Vaccines Revenue by Company (2019-2024) ($ Millions)
Table 18. Global Viral Vaccines Revenue Market Share by Company (2019-2024)
Table 19. Global Viral Vaccines Sale Price by Company (2019-2024) & (USD/MT)
Table 20. Key Manufacturers Viral Vaccines Producing Area Distribution and Sales Area
Table 21. Players Viral Vaccines Products Offered
Table 22. Viral Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Viral Vaccines Sales by Geographic Region (2019-2024) & (K MT)
Table 26. Global Viral Vaccines Sales Market Share Geographic Region (2019-2024)
Table 27. Global Viral Vaccines Revenue by Geographic Region (2019-2024) & ($ millions)
Table 28. Global Viral Vaccines Revenue Market Share by Geographic Region (2019-2024)
Table 29. Global Viral Vaccines Sales by Country/Region (2019-2024) & (K MT)
Table 30. Global Viral Vaccines Sales Market Share by Country/Region (2019-2024)
Table 31. Global Viral Vaccines Revenue by Country/Region (2019-2024) & ($ millions)
Table 32. Global Viral Vaccines Revenue Market Share by Country/Region (2019-2024)
Table 33. Americas Viral Vaccines Sales by Country (2019-2024) & (K MT)
Table 34. Americas Viral Vaccines Sales Market Share by Country (2019-2024)
Table 35. Americas Viral Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 36. Americas Viral Vaccines Revenue Market Share by Country (2019-2024)
Table 37. Americas Viral Vaccines Sales by Type (2019-2024) & (K MT)
Table 38. Americas Viral Vaccines Sales by Application (2019-2024) & (K MT)
Table 39. APAC Viral Vaccines Sales by Region (2019-2024) & (K MT)
Table 40. APAC Viral Vaccines Sales Market Share by Region (2019-2024)
Table 41. APAC Viral Vaccines Revenue by Region (2019-2024) & ($ Millions)
Table 42. APAC Viral Vaccines Revenue Market Share by Region (2019-2024)
Table 43. APAC Viral Vaccines Sales by Type (2019-2024) & (K MT)
Table 44. APAC Viral Vaccines Sales by Application (2019-2024) & (K MT)
Table 45. Europe Viral Vaccines Sales by Country (2019-2024) & (K MT)
Table 46. Europe Viral Vaccines Sales Market Share by Country (2019-2024)
Table 47. Europe Viral Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 48. Europe Viral Vaccines Revenue Market Share by Country (2019-2024)
Table 49. Europe Viral Vaccines Sales by Type (2019-2024) & (K MT)
Table 50. Europe Viral Vaccines Sales by Application (2019-2024) & (K MT)
Table 51. Middle East & Africa Viral Vaccines Sales by Country (2019-2024) & (K MT)
Table 52. Middle East & Africa Viral Vaccines Sales Market Share by Country (2019-2024)
Table 53. Middle East & Africa Viral Vaccines Revenue by Country (2019-2024) & ($ Millions)
Table 54. Middle East & Africa Viral Vaccines Revenue Market Share by Country (2019-2024)
Table 55. Middle East & Africa Viral Vaccines Sales by Type (2019-2024) & (K MT)
Table 56. Middle East & Africa Viral Vaccines Sales by Application (2019-2024) & (K MT)
Table 57. Key Market Drivers & Growth Opportunities of Viral Vaccines
Table 58. Key Market Challenges & Risks of Viral Vaccines
Table 59. Key Industry Trends of Viral Vaccines
Table 60. Viral Vaccines Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Viral Vaccines Distributors List
Table 63. Viral Vaccines Customer List
Table 64. Global Viral Vaccines Sales Forecast by Region (2025-2030) & (K MT)
Table 65. Global Viral Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 66. Americas Viral Vaccines Sales Forecast by Country (2025-2030) & (K MT)
Table 67. Americas Viral Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 68. APAC Viral Vaccines Sales Forecast by Region (2025-2030) & (K MT)
Table 69. APAC Viral Vaccines Revenue Forecast by Region (2025-2030) & ($ millions)
Table 70. Europe Viral Vaccines Sales Forecast by Country (2025-2030) & (K MT)
Table 71. Europe Viral Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 72. Middle East & Africa Viral Vaccines Sales Forecast by Country (2025-2030) & (K MT)
Table 73. Middle East & Africa Viral Vaccines Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Global Viral Vaccines Sales Forecast by Type (2025-2030) & (K MT)
Table 75. Global Viral Vaccines Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 76. Global Viral Vaccines Sales Forecast by Application (2025-2030) & (K MT)
Table 77. Global Viral Vaccines Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 78. GSK Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 79. GSK Viral Vaccines Product Portfolios and Specifications
Table 80. GSK Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 81. GSK Main Business
Table 82. GSK Latest Developments
Table 83. Merck Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 84. Merck Viral Vaccines Product Portfolios and Specifications
Table 85. Merck Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 86. Merck Main Business
Table 87. Merck Latest Developments
Table 88. Novartis Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 89. Novartis Viral Vaccines Product Portfolios and Specifications
Table 90. Novartis Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 91. Novartis Main Business
Table 92. Novartis Latest Developments
Table 93. Pfizer Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Viral Vaccines Product Portfolios and Specifications
Table 95. Pfizer Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Sanofi Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanofi Viral Vaccines Product Portfolios and Specifications
Table 100. Sanofi Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 101. Sanofi Main Business
Table 102. Sanofi Latest Developments
Table 103. Bayer Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 104. Bayer Viral Vaccines Product Portfolios and Specifications
Table 105. Bayer Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 106. Bayer Main Business
Table 107. Bayer Latest Developments
Table 108. Zoetis Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 109. Zoetis Viral Vaccines Product Portfolios and Specifications
Table 110. Zoetis Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 111. Zoetis Main Business
Table 112. Zoetis Latest Developments
Table 113. AstraZeneca Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 114. AstraZeneca Viral Vaccines Product Portfolios and Specifications
Table 115. AstraZeneca Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 116. AstraZeneca Main Business
Table 117. AstraZeneca Latest Developments
Table 118. Johnson Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 119. Johnson Viral Vaccines Product Portfolios and Specifications
Table 120. Johnson Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 121. Johnson Main Business
Table 122. Johnson Latest Developments
Table 123. CSL Basic Information, Viral Vaccines Manufacturing Base, Sales Area and Its Competitors
Table 124. CSL Viral Vaccines Product Portfolios and Specifications
Table 125. CSL Viral Vaccines Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2019-2024)
Table 126. CSL Main Business
Table 127. CSL Latest Developments
LIST OF FIGURES
Figure 1. Picture of Viral Vaccines
Figure 2. Viral Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Viral Vaccines Sales Growth Rate 2019-2030 (K MT)
Figure 7. Global Viral Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Viral Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Attenuated Vaccine
Figure 10. Product Picture of Inactivated Vaccine
Figure 11. Global Viral Vaccines Sales Market Share by Type in 2023
Figure 12. Global Viral Vaccines Revenue Market Share by Type (2019-2024)
Figure 13. Viral Vaccines Consumed in Hospital
Figure 14. Global Viral Vaccines Market: Hospital (2019-2024) & (K MT)
Figure 15. Viral Vaccines Consumed in Pharmaceutical Factory
Figure 16. Global Viral Vaccines Market: Pharmaceutical Factory (2019-2024) & (K MT)
Figure 17. Viral Vaccines Consumed in Research Institute
Figure 18. Global Viral Vaccines Market: Research Institute (2019-2024) & (K MT)
Figure 19. Viral Vaccines Consumed in Others
Figure 20. Global Viral Vaccines Market: Others (2019-2024) & (K MT)
Figure 21. Global Viral Vaccines Sales Market Share by Application (2023)
Figure 22. Global Viral Vaccines Revenue Market Share by Application in 2023
Figure 23. Viral Vaccines Sales Market by Company in 2023 (K MT)
Figure 24. Global Viral Vaccines Sales Market Share by Company in 2023
Figure 25. Viral Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Viral Vaccines Revenue Market Share by Company in 2023
Figure 27. Global Viral Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Viral Vaccines Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Viral Vaccines Sales 2019-2024 (K MT)
Figure 30. Americas Viral Vaccines Revenue 2019-2024 ($ Millions)
Figure 31. APAC Viral Vaccines Sales 2019-2024 (K MT)
Figure 32. APAC Viral Vaccines Revenue 2019-2024 ($ Millions)
Figure 33. Europe Viral Vaccines Sales 2019-2024 (K MT)
Figure 34. Europe Viral Vaccines Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Viral Vaccines Sales 2019-2024 (K MT)
Figure 36. Middle East & Africa Viral Vaccines Revenue 2019-2024 ($ Millions)
Figure 37. Americas Viral Vaccines Sales Market Share by Country in 2023
Figure 38. Americas Viral Vaccines Revenue Market Share by Country in 2023
Figure 39. Americas Viral Vaccines Sales Market Share by Type (2019-2024)
Figure 40. Americas Viral Vaccines Sales Market Share by Application (2019-2024)
Figure 41. United States Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Viral Vaccines Sales Market Share by Region in 2023
Figure 46. APAC Viral Vaccines Revenue Market Share by Regions in 2023
Figure 47. APAC Viral Vaccines Sales Market Share by Type (2019-2024)
Figure 48. APAC Viral Vaccines Sales Market Share by Application (2019-2024)
Figure 49. China Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Viral Vaccines Sales Market Share by Country in 2023
Figure 57. Europe Viral Vaccines Revenue Market Share by Country in 2023
Figure 58. Europe Viral Vaccines Sales Market Share by Type (2019-2024)
Figure 59. Europe Viral Vaccines Sales Market Share by Application (2019-2024)
Figure 60. Germany Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Viral Vaccines Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Viral Vaccines Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Viral Vaccines Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Viral Vaccines Sales Market Share by Application (2019-2024)
Figure 69. Egypt Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Viral Vaccines in 2023
Figure 75. Manufacturing Process Analysis of Viral Vaccines
Figure 76. Industry Chain Structure of Viral Vaccines
Figure 77. Channels of Distribution
Figure 78. Global Viral Vaccines Sales Market Forecast by Region (2025-2030)
Figure 79. Global Viral Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Viral Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Viral Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Viral Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Viral Vaccines Revenue Market Share Forecast by Application (2025-2030)
Figure 1. Picture of Viral Vaccines
Figure 2. Viral Vaccines Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Viral Vaccines Sales Growth Rate 2019-2030 (K MT)
Figure 7. Global Viral Vaccines Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Viral Vaccines Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Attenuated Vaccine
Figure 10. Product Picture of Inactivated Vaccine
Figure 11. Global Viral Vaccines Sales Market Share by Type in 2023
Figure 12. Global Viral Vaccines Revenue Market Share by Type (2019-2024)
Figure 13. Viral Vaccines Consumed in Hospital
Figure 14. Global Viral Vaccines Market: Hospital (2019-2024) & (K MT)
Figure 15. Viral Vaccines Consumed in Pharmaceutical Factory
Figure 16. Global Viral Vaccines Market: Pharmaceutical Factory (2019-2024) & (K MT)
Figure 17. Viral Vaccines Consumed in Research Institute
Figure 18. Global Viral Vaccines Market: Research Institute (2019-2024) & (K MT)
Figure 19. Viral Vaccines Consumed in Others
Figure 20. Global Viral Vaccines Market: Others (2019-2024) & (K MT)
Figure 21. Global Viral Vaccines Sales Market Share by Application (2023)
Figure 22. Global Viral Vaccines Revenue Market Share by Application in 2023
Figure 23. Viral Vaccines Sales Market by Company in 2023 (K MT)
Figure 24. Global Viral Vaccines Sales Market Share by Company in 2023
Figure 25. Viral Vaccines Revenue Market by Company in 2023 ($ Million)
Figure 26. Global Viral Vaccines Revenue Market Share by Company in 2023
Figure 27. Global Viral Vaccines Sales Market Share by Geographic Region (2019-2024)
Figure 28. Global Viral Vaccines Revenue Market Share by Geographic Region in 2023
Figure 29. Americas Viral Vaccines Sales 2019-2024 (K MT)
Figure 30. Americas Viral Vaccines Revenue 2019-2024 ($ Millions)
Figure 31. APAC Viral Vaccines Sales 2019-2024 (K MT)
Figure 32. APAC Viral Vaccines Revenue 2019-2024 ($ Millions)
Figure 33. Europe Viral Vaccines Sales 2019-2024 (K MT)
Figure 34. Europe Viral Vaccines Revenue 2019-2024 ($ Millions)
Figure 35. Middle East & Africa Viral Vaccines Sales 2019-2024 (K MT)
Figure 36. Middle East & Africa Viral Vaccines Revenue 2019-2024 ($ Millions)
Figure 37. Americas Viral Vaccines Sales Market Share by Country in 2023
Figure 38. Americas Viral Vaccines Revenue Market Share by Country in 2023
Figure 39. Americas Viral Vaccines Sales Market Share by Type (2019-2024)
Figure 40. Americas Viral Vaccines Sales Market Share by Application (2019-2024)
Figure 41. United States Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 42. Canada Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 43. Mexico Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 44. Brazil Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 45. APAC Viral Vaccines Sales Market Share by Region in 2023
Figure 46. APAC Viral Vaccines Revenue Market Share by Regions in 2023
Figure 47. APAC Viral Vaccines Sales Market Share by Type (2019-2024)
Figure 48. APAC Viral Vaccines Sales Market Share by Application (2019-2024)
Figure 49. China Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 50. Japan Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 51. South Korea Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 52. Southeast Asia Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 53. India Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 54. Australia Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 55. China Taiwan Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 56. Europe Viral Vaccines Sales Market Share by Country in 2023
Figure 57. Europe Viral Vaccines Revenue Market Share by Country in 2023
Figure 58. Europe Viral Vaccines Sales Market Share by Type (2019-2024)
Figure 59. Europe Viral Vaccines Sales Market Share by Application (2019-2024)
Figure 60. Germany Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 61. France Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 62. UK Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 63. Italy Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 64. Russia Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 65. Middle East & Africa Viral Vaccines Sales Market Share by Country in 2023
Figure 66. Middle East & Africa Viral Vaccines Revenue Market Share by Country in 2023
Figure 67. Middle East & Africa Viral Vaccines Sales Market Share by Type (2019-2024)
Figure 68. Middle East & Africa Viral Vaccines Sales Market Share by Application (2019-2024)
Figure 69. Egypt Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 70. South Africa Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 71. Israel Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 72. Turkey Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 73. GCC Country Viral Vaccines Revenue Growth 2019-2024 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Viral Vaccines in 2023
Figure 75. Manufacturing Process Analysis of Viral Vaccines
Figure 76. Industry Chain Structure of Viral Vaccines
Figure 77. Channels of Distribution
Figure 78. Global Viral Vaccines Sales Market Forecast by Region (2025-2030)
Figure 79. Global Viral Vaccines Revenue Market Share Forecast by Region (2025-2030)
Figure 80. Global Viral Vaccines Sales Market Share Forecast by Type (2025-2030)
Figure 81. Global Viral Vaccines Revenue Market Share Forecast by Type (2025-2030)
Figure 82. Global Viral Vaccines Sales Market Share Forecast by Application (2025-2030)
Figure 83. Global Viral Vaccines Revenue Market Share Forecast by Application (2025-2030)
